Literature DB >> 28718498

Assessing HIV acquisition risks among men who have sex with men in the United States of America.

Ram K Shrestha1, Stephanie L Sansom1, David W Purcell1.   

Abstract

Men who have sex with men (MSM) can reduce their risk of acquiring human immunodeficiency virus (HIV) by using various prevention strategies and by understanding the effectiveness of each option over the short- and long-term. Strategies examined were: circumcision; insertive anal sex only; consistent, 100% self-reported condom use; and pre-exposure prophylaxis (PrEP). PrEP efficacy was based on three levels of adherence. The cumulative HIV acquisition risk among MSM over periods of 1 year and 10 years were estimated with and without single and combinations of prevention strategies. A Bernoulli process model was used to estimate risk. In the base case with no prevention strategies, the 1-year risk of HIV acquisition among MSM was 8.8%. In contrast, the 1-year risk associated with circumcision alone was 6.9%; with insertive sex only, 5.5%; with 100% self-reported condom use, 2.7%; and with average, high, and very high PrEP adherence, 5.1%, 2.5%, and 0.7%, respectively. The 10-year risk of HIV acquisition among MSM with no prevention strategy was 60.3%. In contrast, that associated with circumcision alone was 51.1%; with insertive sex only, 43.1%; with 100% self-reported condom use, 24.0%; and with average, high, and very high PrEP adherence, 40.5%, 22.2%, and 7.2%, respectively. While MSM face substantial risk of HIV, there are now a number of prevention strategies that reduce risk. Very high adherence to PrEP alone or with other strategies appears to be the most powerful tool for HIV prevention.

Entities:  

Mesh:

Year:  2016        PMID: 28718498      PMCID: PMC5718615     

Source DB:  PubMed          Journal:  Rev Panam Salud Publica        ISSN: 1020-4989


  9 in total

1.  Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.

Authors:  Robert M Grant; Javier R Lama; Peter L Anderson; Vanessa McMahan; Albert Y Liu; Lorena Vargas; Pedro Goicochea; Martín Casapía; Juan Vicente Guanira-Carranza; Maria E Ramirez-Cardich; Orlando Montoya-Herrera; Telmo Fernández; Valdilea G Veloso; Susan P Buchbinder; Suwat Chariyalertsak; Mauro Schechter; Linda-Gail Bekker; Kenneth H Mayer; Esper Georges Kallás; K Rivet Amico; Kathleen Mulligan; Lane R Bushman; Robert J Hance; Carmela Ganoza; Patricia Defechereux; Brian Postle; Furong Wang; J Jeff McConnell; Jia-Hua Zheng; Jeanny Lee; James F Rooney; Howard S Jaffe; Ana I Martinez; David N Burns; David V Glidden
Journal:  N Engl J Med       Date:  2010-11-23       Impact factor: 91.245

2.  Study product adherence measurement in the iPrEx placebo-controlled trial: concordance with drug detection.

Authors:  K Rivet Amico; Julia L Marcus; Vanessa McMahan; Albert Liu; Kimberly A Koester; Pedro Goicochea; Peter L Anderson; David Glidden; Juan Guanira; Robert Grant
Journal:  J Acquir Immune Defic Syndr       Date:  2014-08-15       Impact factor: 3.731

Review 3.  Quantifying sexual exposure to HIV within an HIV-serodiscordant relationship: development of an algorithm.

Authors:  Julie Fox; Peter J White; Jonathan Weber; Geoff P Garnett; Helen Ward; Sarah Fidler
Journal:  AIDS       Date:  2011-05-15       Impact factor: 4.177

4.  Prevention of HIV-1 infection with early antiretroviral therapy.

Authors:  Myron S Cohen; Ying Q Chen; Marybeth McCauley; Theresa Gamble; Mina C Hosseinipour; Nagalingeswaran Kumarasamy; James G Hakim; Johnstone Kumwenda; Beatriz Grinsztejn; Jose H S Pilotto; Sheela V Godbole; Sanjay Mehendale; Suwat Chariyalertsak; Breno R Santos; Kenneth H Mayer; Irving F Hoffman; Susan H Eshleman; Estelle Piwowar-Manning; Lei Wang; Joseph Makhema; Lisa A Mills; Guy de Bruyn; Ian Sanne; Joseph Eron; Joel Gallant; Diane Havlir; Susan Swindells; Heather Ribaudo; Vanessa Elharrar; David Burns; Taha E Taha; Karin Nielsen-Saines; David Celentano; Max Essex; Thomas R Fleming
Journal:  N Engl J Med       Date:  2011-07-18       Impact factor: 91.245

5.  Condom effectiveness for HIV prevention by consistency of use among men who have sex with men in the United States.

Authors:  Dawn K Smith; Jeffrey H Herbst; Xinjiang Zhang; Charles E Rose
Journal:  J Acquir Immune Defic Syndr       Date:  2015-03-01       Impact factor: 3.731

6.  HIV sexual transmission risk among serodiscordant couples: assessing the effects of combining prevention strategies.

Authors:  Arielle Lasry; Stephanie L Sansom; Richard J Wolitski; Timothy A Green; Craig B Borkowf; Pragna Patel; Jonathan Mermin
Journal:  AIDS       Date:  2014-06-19       Impact factor: 4.177

7.  Vital Signs: HIV diagnosis, care, and treatment among persons living with HIV--United States, 2011.

Authors:  Heather Bradley; H Irene Hall; Richard J Wolitski; Michelle M Van Handel; Amy E Stone; Michael LaFlam; Jacek Skarbinski; Darrel H Higa; Joseph Prejean; Emma L Frazier; Roshni Patel; Ping Huang; Qian An; Ruiguang Song; Tian Tang; Linda A Valleroy
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2014-11-28       Impact factor: 17.586

8.  HIV testing and risk behaviors among gay, bisexual, and other men who have sex with men - United States.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2013-11-29       Impact factor: 17.586

9.  HIV infection and awareness among men who have sex with men-20 cities, United States, 2008 and 2011.

Authors:  Cyprian Wejnert; Binh Le; Charles E Rose; Alexandra M Oster; Amanda J Smith; Julia Zhu
Journal:  PLoS One       Date:  2013-10-23       Impact factor: 3.240

  9 in total
  1 in total

1.  A Randomized Study of Passive versus Active PrEP Patient Navigation for a Heterogeneous Population at Risk for HIV in South Florida.

Authors:  Susanne Doblecki-Lewis; Stefani Butts; Valeria Botero; Katherine Klose; Gabriel Cardenas; Daniel Feaster
Journal:  J Int Assoc Provid AIDS Care       Date:  2019 Jan-Dec
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.